#IRInformation

In the consolidated fiscal year ending November 2025, derivative valuation gains of 1,892 million yen related to currency forward contracts were recorded as non-operating income. The consolidated dividend payout ratio target remains above 40%, maintaining dividends at least at the previous term’s level.

SanBio Inc. plans to allocate a total of 75,000 subscription rights to shares to 3 employees on January 27, 2026. The exercise period is until January 8, 2036.